title: Should angiotensin converting enzyme (ACE) inhibitors be used routinely after infarction? Perspectives from the Survival and Ventricular Enlargement (SAVE) trial.
authors.affiliation: Royal Brompton, National Heart and Lung Hospital, London.
authors.forename: M S
authors.initials: MS
authors.lastname: Sutton
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000517:prevention & control; D009203:Myocardial Infarction / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000517:prevention & control*; D009206:Myocardium / Q000473:pathology; D015912:Thrombolytic Therapy
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors